Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet's disease

Rheumatology International

Volumn 25, Issue 8, 2005, Pages 599-603

  Erdem, Fuat ^a   Gündoğdu, Mehmet ^a   Kiki, Ilhami ^a   Sari, Refik Ali ^a   Kiziltunç, Ahmet ^a  

^a ATATURK UNIVERSITY   (Turkey)

Author keywords

Angiogenic cytokines; Basic fibroblast growth factor; Beh et's disease; Vascular endothelial growth factor

Indexed keywords

ACUTE PHASE PROTEIN; BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; VASCULOTROPIN;

ADULT; AGE; ARTICLE; BEHCET DISEASE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; MEASUREMENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE;

EID: 26244441020     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-004-0484-7     Document Type: Article

References (23)

1. Yazici H, Yurdakul S, Hamuryudan V (1999) Behçet's syndrome. Curr Opin Rheumatol 11:53-57
2. Saglam K, Yilmaz MI, Saglam A et al (2002) Levels of circulating intercellular adhesion molecule-1 in patients with Behçet's disease. Rheumatol Int 21:146-148
3. Kontogiannis V, Powell RJ (2000) Behçet's disease. Postgrad Med J 76:629-637
4. Sakane T, Takeno M, Suzuki N, Inaba G (1999). Behçet's disease. N Engl J Med 341:1284-1291
5. Gul A (2001) Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 19 [Suppl]:S6-S12
6. Drouart M, Saas P, Billot M, Cedoz JP, Tiberghien P, Wendling D, Toussirot E (2003) High serum vascular endothelial growth factor correlates with disease activity of spondylarthropathies. Clin Exp Immunol 132:158-162
7. Navarro C, Candia-Zuniga, Silveira LH, Ruiz V, Gaxiola M, Avila MC, Amigo MC (2002) Vascular endothelial growth factor plasma levels in patients with systemic lupus erythematosus and primary antiphospholipid syndrome. Lupus 11:21-24
8. Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D et al (2000) Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 96:2240-2245
9. Robak E, Wozniacka A, Sysa-Jedrzejowska A, Stepien H, Robak T (2002) Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus. Lupus 11:348-355
10. Robak E, Wozniacka A, Sysa-Jedrzejowska A et al (2001) Serum levels of angiogenic cytokines in systemic lupus erythematosus and their correlation with disease activity. Eur Cytokine Netw 12:445-452
11. Harada M, Mitsuyama K, Yoshida H et al (1998) Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol 27 377-380
12. Kikuchi K, Kubo M, Kadano T, Yazawa N, Ihn H, Tamaki K (1998) Serum concentrations of vascular endothelial growth factor in collagen diseases. Br J Dermatol 139:1049-1051
13. Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, Ayed K (2002) Cytokine profile in Behcet's disease patients. Relationship with disease activity. Scand J Rheumatol 31:205-210
14. Kiziltunç A, Yildirim AK, Keles MS, Koçer I, Aksoy H, Bas oǧlu M et al (2003) Serum soluble intercellular adhesion molecule-1, interleukin-8 and interleukin-6 levels in patients with Behcet's disease. The Pain Clinic 15:159-165
15. International Study Group for Behçet's disease (1990) Criteria for diagnosis of Behçet's Disease. Lancet 335:1078-1080
16. Evereklioǧlu C, Yürekli M, Er H et al (2000) Increased plasma adrenomedullin levels in patients with Behçet's disease. Dermatology 201:312-315
17. Larsson A, Sköldenberg E, Ericson H (2002) Serum and plasma levels of FGF-2 and VEGF in healthy blood donors. Angiogenesis 5:107-110
18. Chambers JC, Haskard DO, Kooner JS (2001) Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. JACC 37:517-520
19. Leiba M, Sidi Y, Gur H, Leiba A, Ehrenfeld M (2001) Behcet's disease and thrombophilia. Ann Rheum Dis 60:1081-1085
20. Demirer S, Sengul N, Yardel MA, Tuzuner A et al (2000) Haemostasis in patients with Behçet's disease. Eur J Vasc Endovasc Surg 19:570-574
21. Williams FM, Parmar K, Hughes GR, Hunt BJ (2000) Systemic endothelial cell markers in primary antiphospholipid syndrome. Thromb Haemost 84:742-746
22. Lee S, Joo YS, Kim Wu et al (2001) Vascular endothelial growth factor levels in serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol 19:321-324
23. Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, Kaklamanis P, Orfanos CE (2000) Adamantiades-Behcet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 292:279-84